Percentage Correlation of Thymoma with Myasthenia Gravis
Approximately one-third (30-35%) of patients with thymoma have myasthenia gravis, while 10-15% of patients with myasthenia gravis have an underlying thymoma 1.
Thymoma → Myasthenia Gravis Association
The most recent and authoritative data comes from the 2025 NCCN Clinical Practice Guidelines, which clearly states that approximately one-third of patients with thymomas may have myasthenia gravis, making it the most common paraneoplastic syndrome associated with thymoma 1. This represents roughly 30-35% of thymoma patients.
This guideline-level evidence is corroborated by multiple research studies:
- A 2014 case series reported 20-25% of thymoma patients have MG 2
- A 2009 surgical series found similar rates of 20-25% 3
- A 1988 study reported a notably higher rate of 59% in their cohort 4
The variation in reported percentages across studies likely reflects differences in patient populations, referral patterns, and study methodologies. The NCCN guideline figure of approximately one-third (30-35%) represents the most reliable contemporary estimate 1.
Myasthenia Gravis → Thymoma Association
Among patients with myasthenia gravis, 10-15% will have an underlying thymoma 2, 3. This is a critical distinction from the reverse association, as the vast majority of MG patients do not have thymoma.
Research evidence consistently supports this range:
- Multiple studies report 10-20% of myasthenic patients have thymoma 2, 3
- A 1975 series found thymoma in only 4% of their MG cohort, though this represented 37% of myasthenic patients with any thymic pathology 5
Clinical Implications
Pathological Characteristics
When thymoma and MG coexist, certain patterns emerge:
- WHO type B tumors (especially B2-B3) are more common in patients with MG 6, 7
- Type A thymomas and thymic carcinomas are rarely associated with MG 7
- Thymic follicular hyperplasia around the thymoma is significantly more common (29.1% vs 6.3%) in MG patients 7
Prognostic Considerations
The evidence regarding whether MG affects thymoma prognosis is contradictory:
- Some studies suggest MG is associated with worse overall survival and recurrence-free survival 6
- Other studies show no significant difference in survival between thymoma patients with and without MG 7
- Historically, some data suggested thymoma with MG may be less malignant with better survival curves 4
The most recent high-quality evidence from 2021 using propensity score matching suggests MG is a negative prognostic factor (HR = 3.729 for overall survival) 6, though this remains an area of ongoing investigation.
Screening Recommendations
Given these associations:
- All patients with thymoma should be evaluated for myasthenia gravis, as approximately one-third will have this paraneoplastic syndrome
- All patients with myasthenia gravis should undergo chest imaging to evaluate for thymoma, though only 10-15% will have one
- Surgical biopsy should be avoided if thymoma is strongly suspected based on clinical features (presence of MG) and characteristic imaging 1